ストックスクリーナーアプリを入手
19.11
2.70%
-0.53
アフターアワーズ：
19.68
0.57
+2.98%
前日終値:
$19.64
開ける：
$19.64
24時間の取引高:
79,913
Relative Volume:
0.65
時価総額：
$397.85M
収益：
-
当期純損益:
-
株価収益率:
-0.6379
EPS:
-29.96
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-6.28%
1か月 パフォーマンス:
-7.90%
6か月 パフォーマンス:
+46.44%
1年 パフォーマンス:
+50.00%
1日の値動き範囲:
$19.09
$20.45
1週間の範囲:
$19.09
$20.84
52週間の値動き範囲:
$10.92
$24.59
Shoulder Innovations Inc Stock (SI) Company Profile
名前
Shoulder Innovations Inc
セクター
電話
616-566-0286
住所
1535 STEELE AVENUE SW, SUITE B, GRAND RAPIDS
Compare SI vs ABT, MDT, SYK, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SI
Shoulder Innovations Inc
|
19.11 | 408.88M | 0 | 0 | 0 | 0.00 |
ABT
Abbott Laboratories
|
103.36 | 182.09B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
91.62 | 117.54B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
270.01 | 105.63B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.10 | 65.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.77 | 49.67B | 6.30B | 1.07B | 1.09B | 1.8406 |
Shoulder Innovations Inc Stock (SI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-25 | 開始されました | BTIG Research | Buy |
| 2025-08-25 | 開始されました | Goldman | Buy |
| 2025-08-25 | 開始されました | Jefferies | Buy |
| 2025-08-25 | 開始されました | Piper Sandler | Overweight |
| 2023-03-06 | ダウングレード | Compass Point | Neutral → Sell |
| 2023-03-06 | ダウングレード | Wedbush | Neutral → Underperform |
| 2023-03-02 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2023-03-02 | ダウングレード | Compass Point | Buy → Neutral |
| 2023-03-02 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2023-03-01 | ダウングレード | Keefe Bruyette | Outperform → Mkt Perform |
| 2023-01-09 | ダウングレード | Wedbush | Outperform → Neutral |
| 2023-01-06 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-01-06 | ダウングレード | Craig Hallum | Buy → Hold |
| 2023-01-06 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-12-12 | 繰り返されました | Wedbush | Outperform |
| 2022-12-05 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2022-11-21 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2022-11-10 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-10-26 | ダウングレード | Goldman | Buy → Neutral |
| 2022-10-06 | ダウングレード | Wells Fargo | Overweight → Underweight |
| 2022-08-04 | 開始されました | BTIG Research | Buy |
| 2022-06-13 | 開始されました | Wells Fargo | Overweight |
| 2022-06-09 | 再開されました | Morgan Stanley | Equal-Weight |
| 2022-03-21 | 開始されました | BofA Securities | Buy |
| 2022-01-20 | アップグレード | Goldman | Neutral → Buy |
| 2021-12-16 | 開始されました | B. Riley Securities | Buy |
| 2021-11-11 | 開始されました | JP Morgan | Overweight |
| 2021-11-08 | ダウングレード | Keefe Bruyette | Outperform → Mkt Perform |
| 2021-09-27 | 開始されました | Morgan Stanley | Overweight |
| 2021-06-14 | 開始されました | Goldman | Neutral |
| 2021-01-14 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2020-12-22 | 開始されました | Wedbush | Outperform |
| 2020-12-17 | アップグレード | Keefe Bruyette | Mkt Perform → Outperform |
| 2020-12-02 | 開始されました | Craig Hallum | Buy |
| 2020-10-16 | 開始されました | Compass Point | Buy |
| 2020-03-16 | 開始されました | Canaccord Genuity | Buy |
| 2019-12-03 | 開始されました | Keefe Bruyette | Mkt Perform |
| 2019-12-02 | 開始されました | Barclays | Overweight |
| 2019-11-18 | 開始されました | Compass Point | Buy |
すべてを表示
Shoulder Innovations Inc (SI) 最新ニュース
Shoulder Innovations receives FDA clearance for titanium implant - Investing.com
About 10% to 15% of people test positive for metal sensitivity. Shoulder Innovations launches an implant. - Stock Titan
Shoulder Innovations partners with ALM Ortho on implants - Investing.com
Shoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction Procedures - STLtoday.com
Catalyst OrthoScience Announces Settlement of Patent Litigation with Shoulder Innovations - Business Wire
Shoulder Innovations Announces Settlement of Patent Litigation with Catalyst OrthoScience - Ortho Spine News
Shoulder Innovations settles patent dispute with Catalyst By Investing.com - Investing.com India
Shoulder Innovations Settles Patent Dispute With Catalyst OrthoScience - marketscreener.com
Shoulder Innovations settles patent dispute with Catalyst - Investing.com
Shoulder Innovations Announces Settlement of - Moomoo
Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference - Morningstar
Shoulder Innovations to present at Morgan Stanl... - Pluang
Morgan Stanley healthcare conference sets Sept. 15 chat with Shoulder Innovations - Stock Titan
Shoulder Innovations (SI) holder trims stake with 1,196-share sale - Stock Titan
Gilde Healthcare holding B.V. sells $567k in Shoulder Innovations stock - Investing.com Nigeria
Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook - Eastern Progress
Shoulder (SI) Financial Results: Profit Per Share Clears Its Benchmark; Market Response: Shares Close 0.18% Lower in the Latest ReadingEarnings Whisper Number - vinanet.vn
Shoulder (SI) Earnings Snapshot: The Bottom-Line Figure Beats Its Comparison in Latest Trading; Closing Move: Shares Finish 4.99% LowerEarnings Decline Risk - vinanet.vn
Shoulder Innovations (NYSE:SI) COO Matthew Fraser Ahearn Sells 8,314 Shares of Stock - MarketBeat
Shoulder Innovations (SI) COO sells shares under 10b5-1 plan - Stock Titan
Shoulder Innovations (NYSE: SI) plans 22,500-share sale - Stock Titan
Gilde Healthcare sells $213,479 of Shoulder Innovations stock - Investing.com
Gilde Healthcare sells $213,479 of Shoulder Innovations stock By Investing.com - Investing.com UK
SHOULDER INNOVATIONS, INC. SEC Filing (Aug 14, 2026) - Stock Titan
Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer - AOL.com
Shoulder Innovations Inc (SI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Shoulder Innovations at Canaccord Genuity conference: growth, margins rise By Investing.com - Investing.com Canada
Shoulder Innovations at Canaccord Genuity conference: growth, margins rise - Investing.com
Shoulder Innovations announces $4.9M expansion to Byron Center, creating 42 new jobs - FOX 17 West Michigan News
SHOULDER INNOVATIONS, INC. : UBS RAISES TARGET PRICE TO $28 FROM $27 - webull.com
Medical technology company plans new headquarters in Byron Township - Yahoo
Shoulder Innovations elevates Jon Osborne to CCO - medicalbuyer.co.in
Shoulder Innovations, Inc. (NYSE:SI) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Shoulder Innovations (SI) CCO Jonathan Osborne reports stock and option stakes - Stock Titan
Shoulder Innovations, Inc. Announces Appointment of Jon Osborne to Chief Commercial Officer, Effective August 6, 2026 - marketscreener.com
Grand Rapids medtech firm raises 2026 forecast as sales surge 56% - Crain's Grand Rapids Business
Jon Osborne Appointed Chief Commercial Officer at Shoulder Innovations - Kalkine Media
UBS Adjusts Shoulder Innovations Price Target to $28 From $27, Maintains Buy Rating - marketscreener.com
Shoulder Innovations promotes Jon Osborne to commercial chief By Investing.com - Investing.com Australia
Shoulder Innovations promotes Jon Osborne to commercial chief - Investing.com
Shoulder Innovations Promotes Jon Osborne to Commercial Chief - TipRanks
Shoulder Innovations Q2 Earnings Call Highlights - sharewise.com
Major Investor Makes Bold Move in Shoulder Innovations, Inc. Shake-Up - TipRanks
Shoulder Innovations (NYSE:SI) Major Shareholder Sells $166,132.32 in Stock - MarketBeat
Shoulder Innovations (NYSE:SI) Major Shareholder Sells $47,347.00 in Stock - MarketBeat
Shoulder Innovations (SI): Gilde Healthcare sells shares, holds 10.7% stake - Stock Titan
Shoulder Innovations (SI) 10% holder sells 9,433 shares - Stock Titan
Piper Sandler Reiterates "Overweight" Rating for Shoulder Innovations (NYSE:SI) - MarketBeat
BTIG Research Increases Shoulder Innovations (NYSE:SI) Price Target to $26.00 - MarketBeat
BTIG Maintains Shoulder Innovations(SI.US) With Buy Rating, Maintains Target Price $26 - Moomoo
Shoulder Innovations Inc (SI) 財務データ
Shoulder Innovations Inc (SI) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
2.29%
0.75%
大文字化:
|
ボリューム (24 時間):